14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CNAT ranks #10341 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Conatus Pharmaceuticals Inc. Stock Forecast NASDAQ:CNAT

$0.71 (0.71%)

Volume: 166k

Closed: Oct 25, 2021

Hollow Logo Score: -1.428

Conatus Pharmaceuticals Inc. Stock Forecast

$0.71 (0.71%)

Volume: 166k

Closed: Oct 25, 2021

Score Hollow Logo -1.428

Conatus Pharmaceuticals Inc. Stock Price (Quote) NASDAQ:CNAT

$0.71 ( 0.71% ) Monday, 25th Oct 2021

Range Low Price High Price Comment
30 days $0.70 $0.81 Monday, 25th Oct 2021 CNAT stock ended at $0.71. This is 0.71% more than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 2.76% from a day low at $0.70 to a day high of $0.72.
90 days $0.70 $1.11
52 weeks $0.70 $1.98

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2021-10-25 $0.71 $0.72 $0.70 $0.71 166 454
2021-10-22 $0.71 $0.72 $0.70 $0.70 408 456
2021-10-21 $0.72 $0.73 $0.71 $0.71 262 870
2021-10-20 $0.73 $0.74 $0.72 $0.73 153 767
2021-10-19 $0.72 $0.73 $0.71 $0.72 139 573
2021-10-18 $0.71 $0.73 $0.71 $0.71 484 925
2021-10-15 $0.73 $0.73 $0.71 $0.72 294 755
2021-10-14 $0.72 $0.74 $0.71 $0.72 248 346
2021-10-13 $0.73 $0.73 $0.72 $0.72 186 460
2021-10-12 $0.70 $0.73 $0.70 $0.73 187 304
2021-10-11 $0.71 $0.72 $0.70 $0.70 169 880
2021-10-08 $0.71 $0.72 $0.70 $0.71 193 812
2021-10-07 $0.70 $0.73 $0.70 $0.71 94 443
2021-10-06 $0.71 $0.72 $0.70 $0.70 328 837
2021-10-05 $0.73 $0.74 $0.71 $0.71 308 338
2021-10-04 $0.74 $0.75 $0.72 $0.74 333 733
2021-10-01 $0.77 $0.77 $0.74 $0.75 332 297
2021-09-30 $0.75 $0.78 $0.75 $0.76 263 739
2021-09-29 $0.79 $0.80 $0.75 $0.76 342 209
2021-09-28 $0.79 $0.80 $0.77 $0.78 227 233
2021-09-27 $0.79 $0.81 $0.79 $0.79 144 256
2021-09-24 $0.82 $0.83 $0.77 $0.79 191 344
2021-09-23 $0.80 $0.81 $0.80 $0.81 101 829
2021-09-22 $0.78 $0.82 $0.78 $0.81 210 964
2021-09-21 $0.80 $0.81 $0.77 $0.79 331 070
2021-09-20 $0.82 $0.82 $0.78 $0.78 482 199
2021-09-17 $0.83 $0.85 $0.81 $0.81 183 253
2021-09-16 $0.85 $0.85 $0.81 $0.83 365 305
2021-09-15 $0.86 $0.87 $0.84 $0.85 351 406
2021-09-14 $0.90 $0.91 $0.86 $0.88 473 026
2021-09-13 $0.91 $0.91 $0.86 $0.90 218 895
2021-09-10 $0.87 $0.92 $0.85 $0.91 530 853
2021-09-09 $0.83 $0.88 $0.82 $0.87 210 328
2021-09-08 $0.84 $0.85 $0.81 $0.84 169 702
2021-09-07 $0.88 $0.89 $0.84 $0.85 307 909
2021-09-03 $0.82 $0.92 $0.81 $0.87 1 856 443
2021-09-02 $0.82 $0.84 $0.80 $0.82 232 835
2021-09-01 $0.82 $0.84 $0.80 $0.82 444 076
2021-08-31 $0.83 $0.83 $0.79 $0.79 317 341
2021-08-30 $0.85 $0.85 $0.79 $0.82 469 179
2021-08-27 $0.83 $0.83 $0.80 $0.81 230 034
2021-08-26 $0.82 $0.83 $0.80 $0.82 206 281
2021-08-25 $0.82 $0.82 $0.80 $0.82 110 927
2021-08-24 $0.79 $0.82 $0.78 $0.81 256 369
2021-08-23 $0.77 $0.80 $0.76 $0.78 226 550
2021-08-20 $0.76 $0.78 $0.74 $0.77 271 033
2021-08-19 $0.77 $0.79 $0.74 $0.74 510 891
2021-08-18 $0.77 $0.80 $0.76 $0.78 201 645
2021-08-17 $0.80 $0.81 $0.75 $0.77 614 429
2021-08-16 $0.86 $0.86 $0.80 $0.80 491 727

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT